When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Balanopostite

Última revisión: 15 Jan 2026
Última actualización: 23 Oct 2025

Resumen

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • presença de fatores de risco
  • estado não circuncisado
Todos los datos

Otros factores de diagnóstico

  • múltiplos parceiros sexuais ou comportamentos sexuais de alto risco
  • hipo ou hiperpigmentação pós-inflamatória
  • prurido
  • descamação vermelha
  • erosões
  • história pessoal/familiar de atopia (eczema, febre do feno, asma, alergias do tipo I)
  • história pessoal/familiar de psoríase
  • gotejamento urinário
  • hipopigmentação
  • púrpura
  • placas vermelhas
  • vesículas
  • pápulas ou micropápulas
  • pústulas
Todos los datos

Factores de riesgo

  • prepúcio disfuncional congênito ou adquirido
  • estado não circuncisado
  • higiene deficiente, gotejamento e perda de urina
  • lavagem excessiva
  • infecção por papilomavírus humano (HPV)
  • doenças cutâneas inflamatórias
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • swab para microbiologia (coloração de Gram e cultura) e teste de amplificação de ácido nucleico (NAAT)
  • swab para virologia
  • microscopia de campo escuro
Todos los datos

Pruebas diagnósticas que deben considerarse

  • biópsia de pele
  • teste de contato
Todos los datos

Pruebas emergentes

  • dermatoscopia

Algoritmo de tratamiento

Agudo

eczema atópico

dermatite seborreica

dermatite de contato irritativa (DCI)

dermatite alérgica de contato

psoríase

artrite reativa (doença de Reiter)

líquen escleroso

gonorreia

candidíase

balanopostite inespecífica

Balanite de Zoon

carcinoma in situ/neoplasia intraepitelial peniana (NIP)

Colaboradores

Autores

Ien Chan, MD, FRCP

Consultant Dermatologist

Chelsea and Westminster Hospital

London

UK

Divulgaciones

IC declares that he has no competing interests.

David Hawkins, FRCP

Consultant Genitourinary Physician

Chelsea and Westminster Hospital

London

UK

Divulgaciones

DH declares that he has no competing interests.

Christopher B. Bunker, MA, MD, FRCP

Consultant Dermatologist

Honorary Professor of Dermatology

University College London

Chelsea & Westminster Hospitals

London

UK

Divulgaciones

CBB is the owner and CEO of Bruce Shrink Ltd., the publisher of Male Genital Skin Disease, an e-book authored by CBB. He has done consultancy work for the British Skin Foundation. The fee for this work is usually paid to the British Skin Foundation. He is the honorary secretary of the British Skin Foundation, the senior Medical Trustee. CBB has provided advice to MC2, with a pipeline lichens sclerosis product, for which he has not received payment. CBB does a dedicated weekly male genital clinic at University College London Hospitals from which his employer receives income. CBB has a private practice and patients with male genital skin disorders consult him, for which he is remunerated. CBB is a frequent speaker at meetings on male genital dermatology (occasionally, his travel and accommodation are subsidised and he received honoraria) and is in receipt of a grant from a private donor, administered by the British Skin Foundation, to investigate the relationship of lichen sclerosus to penis cancer. He has been appointed to lead the 2024 reiterate of the British Association of Dermatology Guidelines on lichen sclerosus; he has previously been contributor. Occasionally, CBB provides expert advice medical litigation, for which he receives remuneration. He is an author of a number of references cited in this topic.

Revisores por pares

Jesse Mills, MD

Professor of Urology

Director of the Men's Clinic at UCLA

University of California Los Angeles

Los Angeles

CA

Divulgaciones

JM declares that he has no competing interests.

Colm O'Mahony, MD, FRCP, BSc, DIPVen

Consultant in Sexual Health

Department of Sexual Health

Countess of Chester Hospital NHS Foundation Trust

Chester

UK

Divulgaciones

CO declares that he has no competing interests.

Sarah Edwards, MD

Consultant

Department of GU Medicine

West Suffolk Hospital

Suffolk

UK

Divulgaciones

SE declares that she has no competing interests.

David Paige, MD

Consultant Dermatologist and Honorary Senior Lecturer

Dermatology Department

The Royal London Hospital

London

UK

Divulgaciones

DP declares that he has no competing interests.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Edwards SK, Bunker CB, van der Snoek EM, et al. 2022 European guideline for the management of balanoposthitis. J Eur Acad Dermatol Venereol. 2023 Jun;37(6):1104-17.Texto completo  Resumen

Bunker CB, Watchorn RE. Dermatoses of the male genitalia. In: Griffiths C, Barker J, Bleiker T, et al. Rook's textbook of dermatology. 10th ed. Oxford: Wiley; 2024 (in press).

Lewis FM, Tatnall FM, Velangi SS, et al. British Association of Dermatologists guidelines for the management of lichen sclerosus 2018. Br J Dermatol. 2018;178:839-53.Texto completo

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad